High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion

作者:Bonaventura A*; Liberale L; Carbone F; Scopinaro N; Camerini G; Papadia F S; Cordera R; Dallegri F; Adami G F; Montecucco F
来源:Nutrition Metabolism and Cardiovascular Diseases, 2017, 27(5): 423-429.
DOI:10.1016/j.numecd.2017.01.007

摘要

Background and aims: Several studies demonstrated that surgery can improve inflammation parameters, such as C-reactive protein (CRP). Few biomarkers have been investigated to potentially predict type 2 diabetes mellitus (T2DM) remission. We aimed at determining whether pre-surgery serum CRP levels could predict T2DM remission after 3 years in patients undergoing bariatric surgery, especially biliopancreatic diversion (BPD). Methods and results: This study was conducted from 2007 to 2009 at the Surgical Department of the University of Genoa, Italy. Forty-four patients with T2DM undergoing BPD (n = 38) or Rouxen- Y gastric bypass (n = 6) were enrolled. The primary endpoint was to evaluate whether presurgery CRP levels could predict T2DM partial remission at 3-year follow-up. Secondary endpoints were to assess whether glycaemic, lipid, and inflammatory parameters modified during the follow-up. At baseline, patients with T2DM ranged from overweight to morbid obesity, had mild dyslipidaemia, and a low-grade inflammation. Bariatric surgery improved body weight, lipid and glycaemic profile both at 1-and 3-year follow-up. Pre-surgery CRP levels progressively decreased at 1-and 3-year follow-up. Among inflammatory pre-surgery parameters, only high CRP levels were shown to predict T2DM partial remission after 3 years. Multivariate analysis confirmed the predictive value of pre-surgery CRP levels independently of age, gender, type of surgery, and body mass index. Conclusion: Bariatric surgery, in particular BPD, improved both metabolic and inflammatory biomarkers at 1-and 3-year follow-up. Pre-surgery high CRP levels predicted 3-year T2DM partial remission, indicating a promising target population to be especially treated with BPD. (C) 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V.

  • 出版日期2017-5